A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum

James D. Smith(Memorial Sloan Kettering Cancer Center), Diane Reidy‐Lagunes(Memorial Sloan Kettering Cancer Center), Karyn A. Goodman(Memorial Sloan Kettering Cancer Center), Jinru Shia(Memorial Sloan Kettering Cancer Center), Garrett M. Nash(Cornell University)

Annals of Surgical Oncology

April 23, 2014

10.1245/s10434-014-3725-3

Cited by 154Open Access

Abstract

Related Papers

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

Guido Rindi, Günter Klöppel, Anne Couvelard et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2007|954

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

Charles G. Moertel, Larry K. Kvols, Michael J. O’Connell et al.|Cancer|1991|839

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

Emmanuel Mitry, Éric Baudin, Michel Ducreux et al.|British Journal of Cancer|1999|495

The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas

Jonathan Strosberg, Domenico Coppola, David S. Klimstra et al.|Pancreas|2010|353

Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document

Ginger J. Gardner, Diane Reidy‐Lagunes, Paola A. Gehrig|Gynecologic Oncology|2011|346